A larger waist circumference is associated with a higher risk of all-cause mortality and decreased life expectancy. Meanwhile ...

A larger waist circumference is associated with a higher risk of all-cause mortality and decreased life expectancy. Meanwhile ...

A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...

Eli Lilly and Company announced on Monday detailed results from SURMOUNT-5, a phase 3b open-label clinical trial, evaluating ...

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

The trends worry health experts, who say the medicines have potential to narrow differences in obesity rates among ...

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

The first head-to-head trial of obesity drugs reveals a clear winner for effective weight loss. But how does it work, and what are the long-term effects? Anna Magee reports ...

Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...

The judge in March refused to allow compounding pharmacies to keep making copies of Zepbound and Mounjaro while the case was ongoing. The Outsourcing Facilities Association, the lead plaintiff in ...